Global koff -rates of polyclonal T-cell populations merge subclonal avidities and predict functionality

Eur J Immunol. 2022 Apr;52(4):582-596. doi: 10.1002/eji.202149597. Epub 2022 Feb 13.

Abstract

The avidity of TCRs for peptide-major histocompatibility complexes (pMHCs) is a governing factor in how T cells respond to antigen. TCR avidity is generally linked to T-cell functionality and there is growing evidence for distinct roles of low and high avidity T cells in different phases of immune responses. While physiological immune responses and many therapeutic T-cell products targeting infections or cancers consist of polyclonal T-cell populations with a wide range of individual avidities, the role of T-cell avidity is usually investigated only in monoclonal experimental settings. In this report, we induced polyclonal T-cell responses with a wide range of avidities toward a model epitope by altered peptide ligands, and benchmarked global avidity of physiological polyclonal populations by investigation of TCR-pMHC koff -rates. We then investigated how varying sizes and avidities of monoclonal subpopulations translate into global koff -rates. Global koff -rates integrate subclonal avidities in a predictably weighted manner and robustly correlate with the functionality of murine polyclonal T-cell populations in vitro and in vivo. Surveying the full avidity spectrum is essential to accurately assess polyclonal immune responses and inform the design of polyclonal T-cell therapeutics.

Keywords: Avidity; T-cell population; TCR; koff-rate.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Antigens
  • Major Histocompatibility Complex
  • Mice
  • Peptides
  • Receptors, Antigen, T-Cell* / genetics
  • T-Lymphocytes*

Substances

  • Antigens
  • Peptides
  • Receptors, Antigen, T-Cell